These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 18583438
1. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing. Patel MX, De Zoysa N, Bernadt M, David A. J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438 [Abstract] [Full Text] [Related]
2. The attitude of patients towards antipsychotic depot treatment. Heres S, Schmitz FS, Leucht S, Pajonk FG. Int Clin Psychopharmacol; 2007 Sep; 22(5):275-82. PubMed ID: 17690596 [Abstract] [Full Text] [Related]
3. Are depot antipsychotics more coercive than tablets? The patient's perspective. Patel MX, de Zoysa N, Bernadt M, Bindman J, David AS. J Psychopharmacol; 2010 Oct; 24(10):1483-9. PubMed ID: 19304865 [Abstract] [Full Text] [Related]
4. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
5. Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with London. Patel MX, Yeung FK, Haddad PM, David AS. J Psychiatr Ment Health Nurs; 2008 Nov; 15(9):758-66. PubMed ID: 18844802 [Abstract] [Full Text] [Related]
7. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H. J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430 [Abstract] [Full Text] [Related]
8. Treatment adherence in schizophrenia and schizoaffective disorder. Goff DC, Hill M, Freudenreich O. J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119 [Abstract] [Full Text] [Related]
9. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients. Fujikawa M, Togo T, Yoshimi A, Fujita J, Nomoto M, Kamijo A, Amagai T, Uchikado H, Katsuse O, Hosojima H, Sakura Y, Furusho R, Suda A, Yamaguchi T, Hori T, Kamada A, Kondo T, Ito M, Odawara T, Hirayasu Y. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):755-60. PubMed ID: 18226436 [Abstract] [Full Text] [Related]
11. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C. Arch Gen Psychiatry; 2005 Jul 01; 62(7):717-24. PubMed ID: 15997012 [Abstract] [Full Text] [Related]
12. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics]. Gutwinski S, Müller P, Koller M. Psychiatr Prax; 2007 Sep 01; 34(6):289-91. PubMed ID: 17806015 [Abstract] [Full Text] [Related]
13. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics]. Samalin L, Abbar M, Courtet P, Guillaume S, Lancrenon S, Llorca PM. Encephale; 2013 Dec 01; 39 Suppl 4():189-203. PubMed ID: 24373464 [Abstract] [Full Text] [Related]
16. [Depot antipsychotics in the year 2011]. Knegtering H, Oolders H, Ruijsink MA, van der Moolen AE. Tijdschr Psychiatr; 2011 Dec 01; 53(2):95-105. PubMed ID: 21319066 [Abstract] [Full Text] [Related]
17. How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed? Hamann J, Mendel R, Heres S, Leucht S, Kissling W. Eur Neuropsychopharmacol; 2010 Apr 01; 20(4):276-9. PubMed ID: 20133108 [Abstract] [Full Text] [Related]